Eyedentity closes SEK15 million first investment round
Norrsken Launcher leads the financing as the Swedish company tests AI-assisted eye screening with Synologen.
Eyedentity is starting with an encounter that already happens at the optician: a routine photograph of the back of the eye. Its initial clinical focus is uveal melanoma, where identifying a suspicious lesion can trigger referral for specialist assessment.
A live pilot with Synologen gives the team a setting to test that workflow in independent optician practices. The company is still working toward regulatory approval; this first financing backs the transition from clinical development toward a product that can be used more broadly in eye care.
Use of funds
Obtain regulatory approval for the first product
Develop additional diagnostic capabilities
Expand the team and deployment in eye care